KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $80.4 million.

  • Twist Bioscience's Total Current Liabilities rose 1549.98% to $80.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $80.4 million, marking a year-over-year increase of 1549.98%. This contributed to the annual value of $91.4 million for FY2025, which is 2873.0% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Total Current Liabilities is $80.4 million, which was up 1549.98% from $91.4 million recorded in Q3 2025.
  • Twist Bioscience's Total Current Liabilities' 5-year high stood at $92.7 million during Q2 2022, with a 5-year trough of $40.4 million in Q1 2021.
  • In the last 5 years, Twist Bioscience's Total Current Liabilities had a median value of $73.5 million in 2023 and averaged $74.5 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 11571.34% in 2021, then plummeted by 2219.66% in 2023.
  • Twist Bioscience's Total Current Liabilities (Quarter) stood at $80.0 million in 2021, then rose by 4.75% to $83.8 million in 2022, then fell by 22.2% to $65.2 million in 2023, then rose by 6.77% to $69.6 million in 2024, then increased by 15.5% to $80.4 million in 2025.
  • Its Total Current Liabilities stands at $80.4 million for Q4 2025, versus $91.4 million for Q3 2025 and $87.1 million for Q2 2025.